Literature DB >> 15533448

Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.

P K Nandi1, J-C Nicole.   

Abstract

The infectious agent of transmissible spongiform encephalopathies (TSE) has been considered to be PrP(SC), a structural isoform of cellular prion protein PrP(C). PrP(SC) can exist as oligomers and/or as amyloid polymers. Nucleic acids induce structural conversion of recombinant prion protein PrP and PrP(C) to PrP(SC) form in solution and in vitro. Here, we report that nucleic acids, by interacting with PrP in solution, produce amyloid fibril and fibres of different morphologies, similar to those identified in the diseased brains. In addition, the same interaction produces polymer lattices and spherical amyloids of different dimensions (15-150 nm in diameters). The polymer lattices show apparent morphological similarity to the two-dimensional amyloid crystals obtained from linear amyloids isolated in vivo. The spherical amyloids structurally resemble "spherical particles" observed in natural spongiform encephalopathy (SE) and in scrapie-infected brains (TSE). We suggest that spherical amyloids, PrP(SC)-amylospheroids, are probable constituents of the coat of the spherical particles found in vivo and the latter can act as protective coats of the SE and TSE agents in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533448     DOI: 10.1016/j.jmb.2004.09.080

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Formation of native prions from minimal components in vitro.

Authors:  Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

3.  Defined DNA sequences promote the assembly of a bacterial protein into distinct amyloid nanostructures.

Authors:  Rafael Giraldo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

4.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

Review 5.  The peculiar interaction between mammalian prion protein and RNA.

Authors:  Mariana P B Gomes; Yraima Cordeiro; Jerson L Silva
Journal:  Prion       Date:  2008-04-11       Impact factor: 3.931

6.  Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity.

Authors:  Kazuyoshi Murakami; Fumiko Nishikawa; Ken Noda; Takashi Yokoyama; Satoshi Nishikawa
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

7.  Self-propagating beta-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world.

Authors:  C P J Maury
Journal:  Orig Life Evol Biosph       Date:  2009-03-20       Impact factor: 1.950

8.  Nucleic acid induced unfolding of recombinant prion protein globular fragment is pH dependent.

Authors:  Alakesh Bera; Pradip K Nandi
Journal:  Protein Sci       Date:  2014-10-28       Impact factor: 6.725

9.  The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation.

Authors:  Yraima Cordeiro; Julia Kraineva; Mariana P B Gomes; Marilene H Lopes; Vilma R Martins; Luís M T R Lima; Débora Foguel; Roland Winter; Jerson L Silva
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

10.  Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.

Authors:  Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew F Hill
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.